Items where Author is "Sullivan, AH"

Journal article

VADAKEKOLATHU NARAYANAN, J., MINDEN, M.D., HOOD, T., CHURCH, S.E., REEDER, S., ALTMANN, H., SULLIVAN, A.H., VIBOCH, E.J., PATEL, T., IBRAHIMOVA, N., WARREN, S.E., ARRUDA, A., LIANG, Y., SMITH, T.H., FOULDS, G.A., BAILEY, M.D., GOWEN-MACDONALD, J., MUTH, J., SCHMITZ, M., POCKLEY, A.G., CESANO, A., VALK, P.J.M., LÖWENBERG, B., BORNHÄUSER, M., TASIAN, S.K., RETTIG, M.P., DAVIDSON-MONCADA, J., DIPERSIO, J.F. and RUTELLA, S., 2020. Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia. Science Translational Medicine, 12 (546): eaaz0463. ISSN 1946-6234

RUTELLA, S., CHURCH, S.E., VADAKEKOLATHU, J., REEDER, S., SULLIVAN, A.H., WARREN, S., BAUGHMAN, J., MUTH, J., PARK, H., URONIS, H., KANG, Y., NG, M.C.H., ENZINGER, P., LEE, K.W., HUBER, K., WYNTER-HORTON, A., LI, D., BANG, Y., DAVIDSON-MONCADA, J. and CATENACCI, D.V., 2019. Evaluation of tumour microenvironment identifies immune correlates of response to combination immunotherapy with margetuximab (M) and pembrolizumab (P) in HER2+ gastroesophageal adenocarcinoma (GEA). Annals of Oncology, 30 (Supp5), v38-v39. ISSN 0923-7534

RUTELLA, S., CHURCH, S.E., VADAKEKOLATHU, J., VIBOCH, E., SULLIVAN, A.H., HOOD, T., WARREN, S.E., CESANO, A., LA MOTTE-MOHS, R., MUTH, J., LELIÈVRE, H., LOWENBERG, B., DIPERSIO, J.F. and DAVIDSON-MONCADA, J.K., 2018. Adaptive immune gene signatures correlate with response to flotetuzumab, a CD123 × CD3 bispecific Dart® molecule, in patients with relapsed/refractory acute myeloid leukemia. Blood, 132 (S1): 444. ISSN 0006-4971